Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze XERS stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate XERS investment potential.

What is XERS stock price today?

Get real-time XERS stock price, historical data, and price charts on Financhill. Track XERS performance with our advanced analysis tools.

Is XERS a good investment?

Evaluate XERS investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy XERS stock?

To buy XERS stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of XERS?

View detailed market capitalization data and company valuation metrics for XERS on our comprehensive analysis page.

What is the P/E ratio of XERS?

Use our fundamental analysis tools to view XERS P/E ratio and compare valuation metrics with industry peers.

What are XERS earnings?

View XERS earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Xeris Biopharma Holdings, Inc. Stock Predictions

AI Powerhouse Raises Price - But Room Remains

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

XERS
Xeris Biopharma Holdings, Inc.

Last Price:

$6.72

Seasonality Move:

1.07%

7 Day Trial

ALL ACCESS PASS

$ 7

$0.85 Entry Open - Fortune 1000 AI Tech in Demand

Xeris Biopharma Holdings, Inc. Stock Forecast

Over the next 52 weeks, Xeris Biopharma Holdings, Inc. has on average historically risen by 7.6% based on the past 7 years of stock performance.
Xeris Biopharma Holdings, Inc. has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
Is Xeris Biopharma Holdings, Inc. Stock Undervalued?

The current Xeris Biopharma Holdings, Inc. [XERS] share price is $6.72. The Score for XERS is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
XERS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Xeris Biopharma Holdings, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Xeris Biopharma Holdings, Inc. has on average historically risen by 7.6% based on the past 7 years of stock performance.

Xeris Biopharma Holdings, Inc. Stock Rating

Buy

Xeris Biopharma Holdings, Inc. (XERS) is a Buy

Is Xeris Biopharma Holdings, Inc. overpriced?

Xeris Biopharma Holdings, Inc. has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%

Xeris Biopharma Holdings, Inc. Stock Price History

Is XERS stock going to rise?

The current trend is moderately bullish and XERS is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

xerispharma.com

52-Week Data

52-Week High:

10.08

52-Week Low:

3.14

Prediction Charts

Market Cap:

1.1B

Price in USD:

6.72

Volume:

1.4M

Beta:

1.28

Technical Analysis

SMA50:

8.14

SMA100:

7.50

SMA200:

6.07

52-Wk Change:

88.24%

Stock Predictions

Is Xeris Biopharma Holdings, Inc. stock public?

Yes, Xeris Biopharma Holdings, Inc. is a publicly traded company.
What is the Xeris Biopharma Holdings, Inc. stock quote today?

The Xeris Biopharma Holdings, Inc. stock price is 6.72 USD today.
How to buy Xeris Biopharma Holdings, Inc. stock online?

You can buy Xeris Biopharma Holdings, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-14	7.12	7.18	7.32	7.01
Nov-17	7.18	7.26	7.50	7.11
Nov-18	7.18	7.08	7.26	7.00
Nov-19	7.08	7.09	7.25	7.02
Nov-20	7.25	6.84	7.27	6.81
Nov-21	6.82	6.83	6.94	6.71
Nov-24	6.85	7.04	7.06	6.80
Nov-25	7.04	7.10	7.14	6.97
Nov-26	7.15	7.18	7.24	7.01
Nov-28	7.23	7.18	7.24	7.10
Dec-1	7.08	6.96	7.16	6.92
Dec-2	6.96	6.47	6.98	6.47
Dec-3	6.52	6.73	6.85	6.50
Dec-4	6.73	6.72	6.90	6.65

Xeris Biopharma Holdings, Inc. Earnings

Xeris Biopharma Holdings, Inc. Earnings Report: Per Share Xeris Biopharma Holdings, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Xeris Biopharma Holdings, Inc. Forecast Revenue Growth

Xeris Biopharma Holdings, Inc. Stock Analysis: Historical quarterly revenues per share for Xeris Biopharma Holdings, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and an increase next year of $0.35 per share.

* Xeris Biopharma Holdings, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.